Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.

Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE.

Arch Intern Med. 2012 May 14;172(9):704-12. doi: 10.1001/archinternmed.2012.777.

PMID:
22782199
2.

Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.

Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE.

Arch Intern Med. 2011 Jul 25;171(14):1270-8. doi: 10.1001/archinternmed.2011.306.

PMID:
21788542
3.

Determinants of antimicrobial resistance in Escherichia coli strains isolated from faeces and urine of women with recurrent urinary tract infections.

den Heijer CD, Beerepoot MA, Prins JM, Geerlings SE, Stobberingh EE.

PLoS One. 2012;7(11):e49909. doi: 10.1371/journal.pone.0049909. Epub 2012 Nov 16.

4.

[A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study)].

Beerepoot MA, Stobberingh EE, Geerlings SE.

Ned Tijdschr Geneeskd. 2006 Mar 11;150(10):574-5. Dutch.

PMID:
16566424
6.

Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial.

Stamm WE, Counts GW, Wagner KF, Martin D, Gregory D, McKevitt M, Turck M, Holmes KK.

Ann Intern Med. 1980 Jun;92(6):770-5.

PMID:
6992677
7.

Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.

Meier S, Weber R, Zbinden R, Ruef C, Hasse B.

Infection. 2011 Aug;39(4):333-40. doi: 10.1007/s15010-011-0132-6. Epub 2011 Jun 25.

PMID:
21706226
8.

The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.

Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ, McDermott T, Murphy P, Grainger R, Fennell JP, Thornhill JA.

BJU Int. 2012 Apr;109(8):1198-206. doi: 10.1111/j.1464-410X.2011.10528.x. Epub 2011 Aug 24.

9.

Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies.

Geerlings SE, Beerepoot MA, Prins JM.

Infect Dis Clin North Am. 2014 Mar;28(1):135-47. doi: 10.1016/j.idc.2013.10.001. Epub 2013 Dec 7. Review.

PMID:
24484580
10.

Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis.

Beerepoot MA, den Heijer CD, Penders J, Prins JM, Stobberingh EE, Geerlings SE.

Clin Microbiol Infect. 2012 Apr;18(4):E84-90. doi: 10.1111/j.1469-0691.2012.03773.x. Epub 2012 Feb 13.

11.

Effect of ciprofloxacin combined with sulfamethoxazole-trimethoprim prophylaxis on the incidence of urinary tract infections after kidney transplantation.

Wojciechowski D, Chandran S.

Transplantation. 2013 Aug 27;96(4):400-5. doi: 10.1097/TP.0b013e3182962cab.

PMID:
23698597
12.

Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.

Hibberd PL, Tolkoff-Rubin NE, Doran M, Delvecchio A, Cosimi AB, Delmonico FL, Auchincloss H Jr, Rubin RH.

Online J Curr Clin Trials. 1992 Aug 11;Doc No 15:[4083 words; 46 paragraphs].

PMID:
1343609
13.

Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs.

Butler CC, Hillier S, Roberts Z, Dunstan F, Howard A, Palmer S.

Br J Gen Pract. 2006 Sep;56(530):686-92.

14.

Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial.

Lee BB, Toh SL, Ryan S, Simpson JM, Clezy K, Bossa L, Rice SA, Marial O, Weber G, Kaur J, Boswell-Ruys C, Goodall S, Middleton J, Tudehope M, Kotsiou G.

BMC Urol. 2016 Apr 16;16:18. doi: 10.1186/s12894-016-0136-8.

15.

Trimethoprim/sulfamethoxazole resistance in urinary tract infections.

Guneysel O, Onur O, Erdede M, Denizbasi A.

J Emerg Med. 2009 May;36(4):338-41. doi: 10.1016/j.jemermed.2007.08.068. Epub 2008 Mar 6.

PMID:
18325714
16.
17.

Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.

Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.

Pediatrics. 2004 Oct;114(4):e469-76.

PMID:
15466073
18.

Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates.

Burman WJ, Breese PE, Murray BE, Singh KV, Batal HA, MacKenzie TD, Ogle JW, Wilson ML, Reves RR, Mehler PS.

Am J Med. 2003 Oct 1;115(5):358-64.

PMID:
14553870
19.
20.

Cost-effectiveness of cranberries vs antibiotics to prevent urinary tract infections in premenopausal women: a randomized clinical trial.

Bosmans JE, Beerepoot MA, Prins JM, ter Riet G, Geerlings SE.

PLoS One. 2014 Apr 4;9(4):e91939. doi: 10.1371/journal.pone.0091939. eCollection 2014.

Supplemental Content

Support Center